GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Cash Flow from Investing

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Cash Flow from Investing : RM-0.19 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Mar. 2024, Malaysian Genomics Resource Centre Bhd spent RM0.19 Mil on purchasing property, plant, equipment. It gained RM0.00 Mil from selling property, plant, and equipment. It spent RM0.00 Mil on purchasing business. It gained RM0.00 Mil from selling business. It spent RM0.00 Mil on purchasing investments. It gained RM0.00 Mil from selling investments. It paid RM0.00Mil for net Intangibles purchase and sale. And it paid RM0.00 Mil for other investing activities. In all, Malaysian Genomics Resource Centre Bhd spent RM0.19 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Mar. 2024.


Malaysian Genomics Resource Centre Bhd Cash Flow from Investing Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Cash Flow from Investing Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.58 -1.82 -1.13 31.17 -3.89

Malaysian Genomics Resource Centre Bhd Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Mar24
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.66 0.53 0.82 - -0.19

Malaysian Genomics Resource Centre Bhd Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Malaysian Genomics Resource Centre Bhd's Cash Flow from Investing for the fiscal year that ended in Jun. 2021 is calculated as:

Malaysian Genomics Resource Centre Bhd's Cash Flow from Investing for the quarter that ended in Mar. 2024 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Malaysian Genomics Resource Centre Bhd's purchase of property, plant, equipment for the three months ended in Mar. 2024 was RM-0.19 Mil. It means Malaysian Genomics Resource Centre Bhd spent RM0.19 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Malaysian Genomics Resource Centre Bhd's sale of property, plant, equipment for the three months ended in Mar. 2024 was RM0.00 Mil. It means Malaysian Genomics Resource Centre Bhd gained RM0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Malaysian Genomics Resource Centre Bhd's purchase of business for the three months ended in Mar. 2024 was RM0.00 Mil. It means Malaysian Genomics Resource Centre Bhd spent RM0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Malaysian Genomics Resource Centre Bhd's sale of business for the three months ended in Mar. 2024 was RM0.00 Mil. It means Malaysian Genomics Resource Centre Bhd gained RM0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Malaysian Genomics Resource Centre Bhd's purchase of investment for the three months ended in Mar. 2024 was RM0.00 Mil. It means Malaysian Genomics Resource Centre Bhd spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Malaysian Genomics Resource Centre Bhd's sale of investment for the three months ended in Mar. 2024 was RM0.00 Mil. It means Malaysian Genomics Resource Centre Bhd gained RM0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Malaysian Genomics Resource Centre Bhd's net Intangibles purchase and sale for the three months ended in Mar. 2024 was RM0.00 Mil. It means Malaysian Genomics Resource Centre Bhd paid RM0.00 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Malaysian Genomics Resource Centre Bhd's cash from discontinued investing activities for the three months ended in Mar. 2024 was 0.00 Mil. It means Malaysian Genomics Resource Centre Bhd paid RM0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Malaysian Genomics Resource Centre Bhd's cash from other investing activities for the three months ended in Mar. 2024 was RM0.00 Mil. It means Malaysian Genomics Resource Centre Bhd paid RM0.00 Mil for other investing activities.


Malaysian Genomics Resource Centre Bhd Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Traded in Other Exchanges
N/A
Address
8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines